Neurodiem, a new digital platform of independent, high-quality scientific content for UK neuro practitioners

With the non-stop influx of scientific data in neurology, healthcare professionals often struggle to stay up to date on the latest developments by searching through multiple journals and pouring through lengthy articles in search of new advances.

To address the challenge, Biogen Inc. established a single, online platform that aggregates high-quality scientific content in 18 neurology topics, in digestible format. The service was developed by listening to neurologists’ needs through extensive desk research, interviews, prototype testing and ongoing user feedback to ensure the service is relevant and constantly improving.

Called Neurodiem, the non-promotional digital platform from Biogen Inc. is available in six languages and is now live in the United Kingdom, United States, France, Germany, Italy, Spain, Canada and Japan. The scientific information on the platform is entirely objective and independent from Biogen. It is selected, written, and published exclusively by independent scientific writers and editorial partners, who endure ongoing relationships with faculty from academic institutes, and hospitals worldwide. In 2020, the platform features over 3000 daily summaries from key publications, exclusive presentations and interviews from over 70 key medical experts on emerging topics, real-time highlights from 13 international neurology conferences, and access to over 900 full-text articles from renowned neurology journals.

COVID-19 has forced us to use more online resources to keep ourselves up-to-date,” says Rhys Davies, Consultant Neurologist, Liverpool.

I had not previously made much use of online video lectures. However, now I’ve discovered I find, in particular, its “library” of short lectures from key opinion leaders very useful, in terms of subject selection, content and format!”

More than 7,000 healthcare professionals, including over 4000 neurologists, registered to the platform worldwide in less than one year. For 2020, Biogen Inc. plans on launching the Neurodiem App in the UK to ease access of information on the go. Additionally, the digital team behind the platform is strongly focusing on improving the user experience through advanced personalisation, as a means to provide healthcare professionals in neurology with the best and most convenient service to stay up-to-date in their ever-evolving field.

Learn more on Neurodiem is free and exclusive to healthcare professionals.

Neurodiem is a service provided by Biogen MA Inc. The information presented on Neurodiem will in no way be selected, modified or altered by Biogen.